May Daher: The Promise of iPSC-derived CAR-NK Cells for Autoimmune Disease
May Daher, Physician scientist at MD Anderson Cancer Center, shared a post by Waggoner Lab, adding:
“It was a pleasure writing this preview with Katy Rezvani, in Cell highlighting this first-in-human trial showing the promise of iPSC-derived CAR-NK cells for autoimmune disease! The future is bright.”
Quoting Waggoner Lab‘s post:
“Cell preview by Katy Rezvani, May Daher iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis.”
Title: iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis
Authors: May Daher, Katayoun Rezvani
Read the Full Article.
Title: An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
Authors: Xiaobing Wang, Yi Zhang, Yi Jin, Lie Dai, Yanan Yue, Jiapan Hu, Xin Liu, Kun Pang, Songying Ye, Yue Chen, Wenjing Ye, Xiaofei Shi, Xin Ma, Lehang Guo, Yanfang Liu, Na Ta, Xiaofang Zhu, Li Lin, Jiazheng Wang, Ran Yan, Ping Wang, Xiaobin Song, Yixuan Zhou, Lina Zhou, Qing Wang, Tongxiang Guan, Ting Li, Ling Zhou, Weihua Pan, Yanran He, Xin Wu, Yingyong Xu, Luhan Yang, Huji Xu
Read the Full Article.
More p[osts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023